Press Releases
- Active Biotech's Cancer Project ANYARA Featured in Journal of Clinical Oncology July 28, 2009 08:30 (CEST)
- Number of shares and votes in Active Biotech June 30, 2009 08:30 (CEST)
- Teva Completes Enrollment in Second Oral Laquinimod Phase III MS Clinical Trial June 25, 2009 14:00 (CEST)
- Active Biotech's rights issue substantially oversubscribed June 15, 2009 08:30 (CEST)
- Active Biotech Presents Data regarding the 57-57 SLE Project at EULAR June 11, 2009 08:30 (CEST)
- Active Biotech Completes Patient Enrollment to TASQ Clinical Phase II study June 8, 2009 08:30 (CEST)
- Active Biotech Completes Patient Enrollment to ANYARA Phase III Clinical Trial June 1, 2009 08:30 (CEST)
- Announcement of prospectus regarding rights issue in Active Biotech AB (publ) May 18, 2009 08:30 (CEST)
- Annual General Meeting of Active Biotech AB May 8, 2009 08:30 (CEST)
- NEW DATA ILLUSTRATE NOVEL MECHANISM OF ACTION OF LAQUINIMOD, AN ORAL COMPOUND FOR THE TREATMENT OF MULTIPLE SCLEROSIS April 28, 2009 15:00 (CEST)